https://www.live-feeds.com/feed/exclusive-ge-healthcare-to-buy-sofie-for-nearly-1-billion-to-grow-medical-imaging-businessContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/exclusive-ge-healthcare-to-buy-sofie-for-nearly-1-billion-to-grow-medical-imaging-businesshttps://www.live-feeds.com/feed/exclusive-ge-healthcare-to-buy-sofie-for-nearly-1-billion-to-grow-medical-imaging-business#u110443Thu, 08 Oct 2026 10:46:54 +0000GE HealthCare has agreed to purchase radiopharmaceutical company Sofie Biosciences for $945 million, expanding its medical-imaging and fast-growing imaging drug operations. The transaction will provide GE HealthCare with a final mile footprint for positron emission tomography radiopharmaceutical supply across the United States. Trilantic North America is selling Sofie Biosciences to the buyer. Financial institutions and analysts have reacted to the deal, with Needham reiterating its stock rating for GE HealthCare and noting the move vertically integrates the company radiopharma portfolio.Why i